NGEN
NervGen Pharma Corp. Common stock
NASDAQ · Healthcare · Biotechnology · CA
$2.33
+0.43%Institutional positioning
13F filings over the trailing two quarters
New 46Increased 0Reduced 0Sold out 45
| Filer | Action | Shares | Filed |
|---|---|---|---|
| PFG INVESTMENTS, LLC | New Position | 201,000 | Apr 27, 2026 |
| BANK OF AMERICA CORP /DE/ | New Position | 200,656 | May 18, 2026 |
| MARSHALL WACE, LLP | New Position | 200,359 | May 15, 2026 |
| ROYAL BANK OF CANADA | New Position | 171,961 | May 15, 2026 |
| INTEGRATED WEALTH CONCEPTS LLC | New Position | 86,815 | May 15, 2026 |
| VALLEY FORGE INVESTMENT CONSULTANTS INC ADV | New Position | 77,698 | Apr 21, 2026 |
| BANK OF MONTREAL /CAN/ | New Position | 62,900 | May 13, 2026 |
| CAPTRUST FINANCIAL ADVISORS | New Position | 62,367 | May 15, 2026 |
| UBS GROUP AG | New Position | 61,517 | May 5, 2026 |
| ADVISOR GROUP HOLDINGS, INC. | New Position | 39,991 | May 15, 2026 |
| PATRIOT FINANCIAL GROUP INSURANCE AGENCY, LLC | New Position | 37,000 | Apr 22, 2026 |
| COMMONWEALTH EQUITY SERVICES, LLC | New Position | 33,350 | Apr 27, 2026 |
| CETERA INVESTMENT ADVISERS | New Position | 31,400 | May 13, 2026 |
| MCKINLEY CARTER WEALTH SERVICES, INC. | New Position | 30,892 | Apr 20, 2026 |
| CITADEL ADVISORS LLC | New Position | 27,800 | Sep 2, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings